venBio Partners LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001776382 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $323M (100.0% shares, 0.0% debt)

Holdings (7)

VTYX VENTYX BIOSCIENCES INC 35.2%

Value $114M Shares 3,461,536 Est. Cost $18.95 Unrealized +56.3%

ALXO ALX ONCOLOGY HLDGS INC 33.9%

Value $109M Shares 9,699,925 Est. Cost $39.31 Unrealized -71.4%

HRMY HARMONY BIOSCIENCES HLDGS IN 17.7%

Value $57.05M Shares 1,035,396 Est. Cost $36.46 Unrealized +50.8%

PHVS PHARVARIS N V 8.0%

Value $25.84M Shares 2,296,710 Est. Cost $31.46 Unrealized -83.3%

— IMPEL PHARMACEUTICALS INC 3.2%

Value $10.35M Shares 2,759,791 Est. Cost $8.85 Unrealized —

— CINCOR PHARMA INC 1.5%

Value $4.712M Shares 383,390 Est. Cost $17.64 Unrealized —

— ELEVATION ONCOLOGY INC 0.5%

Value $1.773M Shares 1,866,339 Est. Cost $13.57 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTYX	VENTYX BIOSCIENCES INC	3,461,536	$114M	35.2%	$18.95	+56.3%	COM	92332V107
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$109M	33.9%	$39.31	-71.4%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	1,035,396	$57.05M	17.7%	$36.46	+50.8%	COM	413197104
PHVS	PHARVARIS N V	2,296,710	$25.84M	8.0%	$31.46	-83.3%	COM	N69605108
—	IMPEL PHARMACEUTICALS INC	2,759,791	$10.35M	3.2%	$8.85	—	COM	45258K109
—	CINCOR PHARMA INC	383,390	$4.712M	1.5%	$17.64	—	COM	17240Y109
—	ELEVATION ONCOLOGY INC	1,866,339	$1.773M	0.5%	$13.57	—	COM	28623U101